NKTR-255
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for NKTR-255, covering 2025-02-13 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma [Phase 1]